1. 2018
  2. Omics-based responses induced by bosentan in human hepatoma HepaRG cell cultures

    Marcelino Rodrigues, R., Kollipara, L., Chaudhari, U., Sachinidis, A., Zahedi, R. P., Sickmann, A., Kopp Schneider, A., Jiang, X., Keun, H., Hengstler, J., Oorts, M., Annaert, P., Hoeben, E., Gijbels, E., De Kock, J., Vanhaecke, T., Rogiers, V. & Vinken, M., 17 Jun 2018, In : Archives of Toxicology. 92, 6, p. 1939-1952 14 p.

    Research output: Contribution to journalArticle

  3. Engineering of a potent nitisinone-insensitive HPD enzyme by directed protein evolution.

    Neuckermans, J., Mertens, A., De Kock, J. & Schwaneberg, U., 25 Apr 2018, (Unpublished).

    Research output: Unpublished contribution to conferencePoster

  4. DEvelopment of a high-throughput bacterial inhbition assay for human 4-hydroxyphenylpyruvate dioxygenase in the context of tyrosinemia type 1

    Neukermans, J., Mertens, A., Schwaneberg, U., De Kock, J. & Vanhaecke, T., 2018.

    Research output: Unpublished contribution to conferencePoster

  5. Elafibranor restores lipogenic gene expression in a human skin stem cell-derived non-alcoholic fatty liver disease (NAFLD) model

    Boeckmans, J., Natale, A., Buyl, K., De Kock, J., Rogiers, V., Vanhaecke, T. & Marcelino Rodrigues, R., 2018, Elafibranor restores lipogenic gene expression in a human skin stem cell-derived non-alcoholic fatty liver disease (NAFLD) model. p. 354-355 2 p.

    Research output: Chapter in Book/Report/Conference proceedingMeeting abstract (Book)Research

Previous 1 2 3 4 5 6 7 8 ...12 Next

ID: 109517